Kestra Medical Technologies, Ltd. Common Stock earnings per share and revenue
On Dec 11, 2025, KMTS reported earnings of -0.64 USD per share (EPS) for Q2 26, missing the estimate of -0.60 USD, resulting in a -5.84% surprise. Revenue reached 22.57 million, compared to an expected 21.12 million, with a 6.85% difference. The market reacted with a +5.06% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -0.60 USD, with revenue projected to reach 23.32 million USD, implying an decrease of -6.25% EPS, and increase of 3.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
FAQ
What were Kestra Medical Technologies, Ltd. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Kestra Medical Technologies, Ltd. Common Stock reported EPS of -$0.64, missing estimates by -5.84%, and revenue of $22.57M, 6.85% above expectations.
How did the market react to Kestra Medical Technologies, Ltd. Common Stock's Q2 2026 earnings?
The stock price moved up 5.06%, changed from $24.91 before the earnings release to $26.17 the day after.
When is Kestra Medical Technologies, Ltd. Common Stock expected to report next?
The next earning report is scheduled for Apr 14, 2026.
What are the forecasts for Kestra Medical Technologies, Ltd. Common Stock's next earnings report?
Based on 9
analysts, Kestra Medical Technologies, Ltd. Common Stock is expected to report EPS of -$0.60 and revenue of $23.32M for Q3 2026.